Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · Real-Time Price · USD
2.950
-0.380 (-11.41%)
At close: Nov 4, 2024, 4:00 PM
2.990
+0.040 (1.35%)
After-hours: Nov 4, 2024, 7:38 PM EST

Biora Therapeutics Stock Forecast

BIOR's stock price has decreased by -84.39% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Biora Therapeutics stock has a target of 150, which predicts an increase of 4,984.75% from the current stock price of 2.95.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $150 $150 $150 $150
Change +4984.7% +4984.7% +4984.7% +4984.7%
* Price targets were last updated on Aug 13, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for BIOR is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong Buy Reiterates $150 +4,984.75% Aug 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong Buy Reiterates $150 +4,984.75% Jul 22, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$150
Strong Buy Reiterates $150 +4,984.75% May 16, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$500
Strong Buy Reiterates $500 +16,849.15% Jan 2, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$650$500
Strong Buy Maintains $650$500 +16,849.15% Oct 2, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
1.31M
from 4.00K
Increased by 32,550.00%
Revenue Next Year
2.55M
from 1.31M
Increased by 95.48%
EPS This Year
-9.03
from -78.69
EPS Next Year
-11.83
from -9.03
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
143.99M162.00K1.25M305.00K4.00K1.31M2.55M2.82M
Revenue Growth
12.51%-99.89%669.75%-75.54%-98.69%32,550.00%95.48%10.38%
EPS
-11,716.09-1,751.86-643.27-49.98-78.69-9.03-11.83-10.81
EPS Growth
--------
Forward PE
--------
No. Analysts -----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 1.8M 5.3M 5.8M
Avg 1.3M 2.6M 2.8M
Low 842,800 4,900 24,500

Revenue Growth

Revenue Growth 202420252026
High
44,525.0%
302.0%
126.2%
Avg
32,550.0%
95.5%
10.4%
Low
20,970.0%
-99.6%
-99.0%

EPS Forecast

EPS 202420252026
High -8.82 -9.98 -9.98
Avg -9.03 -11.83 -10.81
Low -9.11 -13.43 -11.47

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.